FDA Approves Expanded Indication for Anktiva in BCG-Unresponsive NMIBC
PharmaMar Joins OncoDaily Grand Rounds at ESMO 2026: Sarcoma Edition as Foundational Partner
Jazz EMERGE 402: Real-World Lurbinectedin Shows Clinically Meaningful Activity in Previously Treated SCLC
The Advocacy Lens - Breast Cancer Awareness Month Special
FFCD-AC: 1L Chemotherapy for Metastatic Recurrence of Ampullary Adenocarcinoma
Ulrika Årehed Kågström: The Hidden Financial Burden of Cancer Beyond Treatment
Men and Breast Cancer: More than just a support system
Giuseppe Curigliano Announces Milan as Host City for ESMO Congress 2028
OncoDaily RT is the dedicated radiation oncology platform of OncoDaily, focused on the rapidly evolving field of radiotherapy and cancer treatment. It covers clinical research, treatment advances, technology, education, and global collaboration, including precision radiotherapy, stereotactic radiotherapy, brachytherapy, adaptive radiotherapy, proton therapy, artificial intelligence, treatment toxicity, survivorship, patient-centered care, and integration with systemic treatments. Through OncoDaily RT, radiation oncologists, medical physicists, researchers, trainees, industry partners, and multidisciplinary cancer care professionals can follow the latest research, emerging technologies, treatment innovations, congress updates, expert perspectives, interviews, articles, social media coverage, and expert-led discussions, while sharing knowledge and advancing radiation oncology worldwide.
